Neuroone Medical Technologies (NMTC) Share-based Compensation (2017 - 2026)

Neuroone Medical Technologies (NMTC) has reported Share-based Compensation for 10 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation fell 81.62% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (down 81.62% YoY), and the FY2025 full-year result was $6.1 million, up 116.17% from the prior year.
• Share-based Compensation rose to $1.1 million in Q2 2026 per NMTC's latest filing, from $1.1 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $6.1 million in Q2 2025 and bottomed at $232716.0 in Q1 2022.
• Historically, Share-based Compensation has averaged $1.7 million across 5 years, with a median of $728299.0 in 2025.
• The sharpest annual moves came in 2024 and 2026: Share-based Compensation surged 1111.6% in 2024, then plunged 81.62% in 2026.
• Over 5 years, Share-based Compensation stood at $300181.0 in 2022, then soared by 837.47% to $2.8 million in 2023, then changed by 0.0% to $2.8 million in 2024, then surged by 116.34% to $6.1 million in 2025, then slumped by 81.49% to $1.1 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $1.1 million, $1.1 million, and $6.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.